MEDICINSKI GLASNIK

202
Medicinski Glasnik, Volumen 6, Number 2, August 2009
6. Ozenoğlu A, Sahin E, Can G, Balci H, Uğur A, hypothesis. J Gerontol A Biol Sci Med Sci 2004;
Hatemi H. Differences in biochemistrical param- 59:178-83.
eters and body composition among adult women
with normal weight, overweight, obesity and morbid
obesity acoording to their BMI. Diabet Bilimi
2006; 4:122-26.
21. De Hert MA, Van Winkel R, Van Eyck D, Hanssens
L, Wampers M, Scheen A, Peuskens J. Prevalance
of the metabolic syndrome in patients with schizophrenia
treated with antipsychotic medication.
7. Rosmond R, Björntorp P. Endocrine and metabolic Schizoph Res 2006; 83:87-93.
aberrations in men with abdominal obesity in relation
to anxio-depressive infirmity. Metabolism
1998; 47:1187-93.
22. Allison DB, Casey DE. Antipsychotic-induced
weight gain: a review of the literature. J Clin Psychiatry
2001; 62 (Suppl):22-31.
8.
9.
10.
Rosmond R, Dalman MF, Björntorp P. Stress-related
cortisol secretion in men: relationships with
abdominal obesity and endocrine, metabolic and
hemodynamic abnormalities. J Clin Endocrinol
Metab 1998; 83:1853-59.
Björntorp P, Holm G, Rosmond R. Hypothalamic
arousal, insulin resistance and Type 2 diabetes mellitus.
Diabet Med 1999; 16:373-83.
Rosmond R, Björntorp P. The hypothalamic-pituitary-adrenal
axis activity as a predictor of cardiovascular
disease, type 2 diabetes and stroke. J
Intern Med 2000; 247:188-97
23.
24.
25.
Blin O, Micallef J. Antipsychotic associated weight
gain and clinical outcome parameters. J Clin Psychiatry
2001; 62 (Suppl):11-21.
Hummer M, Kemmler G, Kurz M, Kurzthaler I,
Oberbauer H, Fleischhacker WW. Weight gain induced
by clozapine. European Neuropsychopharmacol
1995; 5:437-40.
Hinze-Selch D, Schuld A, Kraus T, Kühn M, Uhr
M, Haack M, Pollmächer T. Effects of antidepressants
on weight and on the plasma levels of leptin,
TNF-alpha and soluble TNF receptors: a longitudinal
study in patients treated with amitriptyline
11. Rosmond R, Björntorp P. Blood pressure in relation or paroxetine. Neuropsychopharmacology 2000;
to obesity, insulin and the hypothalamic-pituitary- 23:13-9.
adrenal axis in Swedish men. J Hypertens 1998;
16:1721-6.
26. Zimmermann U, Kraus T, Himmerich H, Schuld
A, Pollmächer T. Epidemiology, implications
12. Alberti KGMM, Zimmet P, Shaw J. Metabolic Syn- and mechanisms underlying drug-induced weight
drome- a new world-wide definition. A Concensus gain in psychiatric patients. J Psychiatr Res 2003;
Statement from the International Diabetes Federa- 37:193-220.
tion. Diabetic Medicine 2006; 23:469-80. 27. Klett CJ, Caffey EM Jr. Weight changes during
13. Groop L, Orho-Melander M. The dysmetabolic treatment with phenothiazine derivatives. J Neu-
syndrom. J Intern Med 2001; 250:105-20.
ropsychiatr 1960; 2:102-8.
14. Nicolls MR. The clinical and biological relation- 28. Singh MM, De Dios LV, Kline NS. Weight as a corship
between Type II diabetes mellitus and Alzhe- relate of clinical response to psychotropic drugs.
imer’s disease. Curr Alzheimer Res 2004; 1:47-54. Psychosomatics 1970; 11:562-70.
15. de la Monte SM, Wands JR. Review of insulin 29. Baptista T, Teneud L, Contreras Q, Alastre T, Burand
insulin-like growth factor expression, signal- guera JL, de Burguera M, de Baptista E, Weiss S,
ing and malfunction in the central nervous system: Hernàndez L. Lithium and body weight gain. Phar-
relevance to Alzheimer’s disease. J Alzheimers Dis macopsychiatry 1995; 28:35-44.
2005; 7:45-61.
30. Garland EJ, Remick RA, Zis AP. Weight gain with
16. Yaffe K, Kanaya A, Lindquist K, Simonsick EM, antidepressants and lithium. J Clin Psychopharma-
Harris T, Shorr RI,et al. The metabolic syndrome, colog 1988; 8:323-30.
inflammation, and risk of cognitive decline. JAMA
2004; 292:2237-42.
31. Vestergaard P, Poulstrup I, Schou M. Prospective
studies on a lithium cohort 3. Tremor, weight gain,
17. Luchsinger JA, Mayeux R. Cardiovascular risk fac- diarrhea, psychologic complaints. Acta Psychiatr
tors and Alzheimer’s disease. Curr Atheroscler Rep Scand 1988; 78:434-41.
2004; 6:261-6.
32. Kerry RJ, Liebling LI, Owen G. Weight changes in
18. Kornhuber HH. Prevention of dementia (including lithium responders. Acta Psychiatric Scand 1970;
Alzheimer’s disease). Gesundheitswesen. 2004; 46:238-43.
66:346-51.
33. Gómez-Ambrosi J, Salvador J, Páramo JA, Orbe
19. Watson GS, Craft S. Modulation of memory by in- J, de Irala J, Diez-Caballero A, Gil MJ, Cienfue-
sulin and glucose: neuropsychological observations gos JA, Frühbeck G. Involvement of leptin in the
in Alzheimer’s disease. Eur J Pharmacol 2004; 490: association between percentage of body fat and
97-113.
cardiovascular risk factors. Clin Biochem 2002;
20. Rasgon N, Jarvik L. Insulin resistance, affective
disorders, and Alzheimer’s disease: review and
35:315-20.